Zoetis (ZTS) Return on Invested Capital (2013 - 2026)
Zoetis' (ZTS) quarterly Return on Invested Capital came in at 0.01% in Q1 2026, little changed year-on-year from 0.01% in Q1 2025, and up 66.85% on a QoQ basis from 0.01% in Q4 2025.
Zoetis (ZTS) Return on Invested Capital (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.
- On a quarterly basis, Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2015 full-year figure at 0.06%, down 119.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
- Over the last five years, Return on Invested Capital for ZTS reached as high as 4.2% in Q4 2023 and fell as low as 0.01% in Q3 2025.
- Historically, Return on Invested Capital has averaged 0.8% across 5 years, with a median of 0.02% in 2022.
- Across the five-year window, Return on Invested Capital jumped 419 bps in 2023 and sank 416 bps in 2024, its largest moves.
- Year by year, Return on Invested Capital stood at 0.02% in 2022, then soared by 23249 bps to 4.2% in 2023, then tumbled by 99 bps to 0.04% in 2024, then plunged by 78 bps to 0.01% in 2025, then surged by 67 bps to 0.01% in 2026.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01% |
| Dec 31, 2025 | 0.01% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.04% |
| Sep 30, 2024 | 1.14% |
| Jun 30, 2024 | 1.07% |
| Mar 31, 2024 | 1.68% |
| Dec 31, 2023 | 4.20% |
| Sep 30, 2023 | 2.94% |
| Jun 30, 2023 | 2.41% |
| Mar 31, 2023 | 0.03% |
| Dec 31, 2022 | 0.02% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.02% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |